NCT02576197View on ClinicalTrials.gov

Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Psoriasis
Interventions
DIETARY_SUPPLEMENT

Probiotic

one capsule per day, containing the probiotic along with the patient's customary psoriasis treatment (excluding systemic treatments)

DIETARY_SUPPLEMENT

Placebo

one capsule per day, containing the placebo, along with the patient's customary psoriasis treatment (excluding systemic treatments)

Trial Locations (1)

03014

Centro Dermatológico Estético de Alicante, Alicante

All Listed Sponsors
collaborator

Korott, S.L.

INDUSTRY

lead

Biopolis S.L.

INDUSTRY

NCT02576197 - Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients | Biotech Hunter | Biotech Hunter